Mitochondrial myopathy

3,981views

Mitochondrial myopathy

Cardiovascular

Cardiovascular

Development of the cardiovascular system
Anatomy of the heart
Anatomy of the superior mediastinum
Anatomy of the inferior mediastinum
Anatomy of the coronary circulation
Anatomy clinical correlates: Heart
Anatomy clinical correlates: Mediastinum
Pressures in the cardiovascular system
Hyperlipidemia
Down syndrome (Trisomy 21)
Edwards syndrome (Trisomy 18)
Patau syndrome (Trisomy 13)
Fragile X syndrome
Huntington disease
Myotonic dystrophy
Friedreich ataxia
Turner syndrome
Klinefelter syndrome
Prader-Willi syndrome
Angelman syndrome
Beckwith-Wiedemann syndrome
Cri du chat syndrome
Williams syndrome
Alagille syndrome (NORD)
Achondroplasia
Polycystic kidney disease
Familial adenomatous polyposis
Familial hypercholesterolemia
Hereditary spherocytosis
Li-Fraumeni syndrome
Marfan syndrome
Multiple endocrine neoplasia
Neurofibromatosis
Tuberous sclerosis
von Hippel-Lindau disease
Albinism
Cystic fibrosis
Gaucher disease (NORD)
Glycogen storage disease type I
Glycogen storage disease type II (NORD)
Glycogen storage disease type III
Glycogen storage disease type IV
Glycogen storage disease type V
Hemochromatosis
Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)
Krabbe disease
Leukodystrophy
Niemann-Pick disease types A and B (NORD)
Niemann-Pick disease type C
Primary ciliary dyskinesia
Sickle cell disease (NORD)
Tay-Sachs disease (NORD)
Alpha-thalassemia
Beta-thalassemia
Wilson disease
Alport syndrome
X-linked agammaglobulinemia
Fabry disease (NORD)
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Hemophilia
Mucopolysaccharide storage disease type 2 (Hunter syndrome) (NORD)
Lesch-Nyhan syndrome
Muscular dystrophy
Ornithine transcarbamylase deficiency
Wiskott-Aldrich syndrome
Mitochondrial myopathy
Autosomal trisomies: Pathology review
Muscular dystrophies and mitochondrial myopathies: Pathology review
Miscellaneous genetic disorders: Pathology review
Hypertension
Baroreceptors
Lipid-lowering medications: Statins
Miscellaneous lipid-lowering medications
Lipid-lowering medications: Fibrates
Microcirculation and Starling forces
ECG basics
ECG intervals
ECG axis
ECG normal sinus rhythm
ECG QRS transition
ECG rate and rhythm
ECG cardiac hypertrophy and enlargement
ECG cardiac infarction and ischemia
Renin-angiotensin-aldosterone system
Myocardial infarction
Tetralogy of Fallot
Atrial septal defect
Ventricular septal defect
Thiazide and thiazide-like diuretics
Adrenergic antagonists: Beta blockers
Calcium channel blockers
ACE inhibitors, ARBs and direct renin inhibitors
Abnormal heart sounds
Normal heart sounds
Action potentials in myocytes
Excitability and refractory periods
Action potentials in pacemaker cells
Cardiac excitation-contraction coupling
Cardiac conduction velocity
Cardiac conduction system
Persistent truncus arteriosus
Atrial fibrillation
Ventricular tachycardia
Ventricular fibrillation
Atrioventricular block
Bundle branch block
Heart failure
Long QT syndrome and Torsade de pointes
Aortic valve disease
Mitral valve disease
Loop diuretics
Peripheral artery disease

Transcript

Watch video only

Primary mitochondrial myopathy is a rare genetic disorder that occurs when there are mutated mitochondria in muscle cells, especially skeletal muscle cells.

These mitochondria are unable to generate adenosine triphosphate, or ATP, which is a form of energy used by our cells.

As a result, muscle cells, which require a lot of energy to function, stop functioning properly.

The mitochondria are the main energy producing factories of a cell, and they do so with the help of the electron transport chain, and the enzyme ATP synthase.

The electron transport chain is made up of complexes of proteins or lipids, called electron carriers, embedded within the inner mitochondrial membrane which pass electrons along like the baton in a relay race.

This movement of electrons helps establish a proton gradient that drives ATP synthase to phosphorylate adenosine diphosphate or ADP into ATP.

Primary mitochondrial myopathy is caused by a mutation either in the mitochondrial DNA or nuclear DNA, which results in the abnormal production of mitochondrial proteins, impairing the function of the electron transport chain.

Mutations in the nuclear DNA are commonly inherited in an autosomal dominant fashion, which means one mutated gene is enough to cause the disease; or autosomal recessive fashion, which means two mutated genes, one from each parent, are needed to cause the disease.

Mutations in the mitochondrial DNA follow maternal inheritance , meaning that only an affected woman can pass on the disease to her children.

This is because, typically during fertilization, the father's mitochondria are left behind while the sperm’s nucleus alone enters the egg.

The exception is the mitochondrial DNA single deletion, a common cause of primary mitochondrial myopathy, which is always sporadic and cannot be transmitted to the offspring.

In primary mitochondrial myopathy, muscle cells are unable to generate ATP, which results in muscle weakness and fatigue.

Sometimes there may also be muscle paincramping, stiffness, or even paralysis of the muscle.

Individuals typically develop exercise intolerance, which is a reduced ability to perform physical activity.

Symptoms vary based on the group of muscles affected.

In most individuals, the first to be affected are the extraocular muscles which control eye movements, which results in progressive external ophthalmoplegia.

Key Takeaways

Mitochondrial myopathies refers to a group of neuromuscular disorders caused by damage to the mitochondria, which are the energy-producing organelles in cells. This damage can disrupt the normal function of muscles and organs. Symptoms may include body weakness, exercise intolerance, loss of muscle mass, and problems with breathing, seizures, ophthalmoplegia (paralysis of eye muscles), and hypotonia (abnormally reduced muscle tone).

Sources

  1. "Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy" Neurology (2018)